Pharma

Taking stock of the drug industry, from the lab to the medicine chest. For a weekly update, sign up for our free Pharmalot newsletter. And subscribe to STAT+ for exclusive coverage and analysis of the pharma industry — from drug pipelines to boardroom shakeups.

Pharma By Madlen Davies, Ivan Ruiz, Jill Langlois, and Rosa Furneaux — The Bureau of Investigative Journalism

‘Held to ransom’: Pfizer plays hardball in Covid-19 vaccine negotiations with Latin American countries

Pfizer insisted some governments cover the potential costs of civil cases that result from its own acts of negligence, fraud, or malice.

Read The Story

Biotech By Elizabeth Cooney

All Coverage

Pharmalot By Ed Silverman

Pharmalittle: Novartis to help make CureVac Covid-19 vaccine; U.K. to speed vaccine approvals for Covid-19 variants

Pharmalot By Ed Silverman

Pharmalittle: A race is on to find alternatives to syringes and needles for vaccines; FDA under pressure to inspect more plants

Pharmalot By Ed Silverman

Pharmalittle: FDA scientists say J&J Covid-19 shot is effective; vaccine makers predict big jump in deliveries this month

First Opinion By William Feehery and Julie Bullock

Three steps can help companies speed FDA approval of new drugs

Pharmalot By Ed Silverman

Access to heart drugs improves in middle-income countries, but still lags compared to wealthy nations

Pharmalot By Ed Silverman

Pharmalittle: Pfizer accused of ‘bullying’ some countries during vaccine talks; FDA to quickly analyze Covid-19 booster shots

Pharmalot By Ed Silverman

Dozens of institutional investors push for ‘fair and equitable’ Covid-19 response

Pharmalot By Ed Silverman

New pledges boost COVAX, but critics say more is needed to ensure global vaccine access

Pharmalot By Ed Silverman

Pharmalittle: Glaxo and Sanofi start new trial of Covid-19 vaccine; AstraZeneca ends a drug’s use for bladder cancer after failed trial

Pharmalot By Ed Silverman

AbbVie smooths over a dispute about alleged theft of trade secrets for a new version of Botox

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Single Pfizer shot is 85% effective in preventing symptomatic Covid-19; Biden to commit $4 billion to COVAX

Pharmalot By Ed Silverman

‘Held to ransom’: Pfizer plays hardball in Covid-19 vaccine negotiations with Latin American countries

How nanotechnology helps mRNA Covid-19 vaccines work

South Africa official explains why world trade rules should be waived to fight Covid-19

The Biden administration’s pandemic agenda must not ignore superbugs

Why drug prescriptions should include diagnoses

All Coverage

Pharmalittle: Novartis to help make CureVac Covid-19 vaccine; U.K. to speed vaccine approvals for Covid-19 variants

Pharmalittle: A race is on to find alternatives to syringes and needles for vaccines; FDA under pressure to inspect more plants

Pharmalittle: Merck will help J&J make its Covid-19 vaccine; Trump used hospital funds to bankroll Warp Speed

A nascent state effort would tax drug makers for not providing clinical evidence for price hikes

New Mexico attorney general accuses Gilead of blocking competition to its HIV medicines

Pharmalittle: J&J Covid-19 vaccine supply will be uneven; pandemic ushers in a ‘golden age of vaccinology’

Up and down the ladder: The latest comings and goings

Pharmalittle: Sarepta wins another FDA nod; Germans balk at AstraZeneca vaccine

The vial is not half empty: New report lays out ways to address the issue of discarded drugs

Pharmalittle: Moderna proceeds with a vaccine trial to combat Covid-19 variant; who will be the next FDA commish?

A U.S. court ruling may force biologics makers to review patent protections

Challenging the link between statins and muscle pain, patients report no difference in aches when taking drug or placebo

Once again, the credit outlook for the pharmaceutical industry is negative

Pharmalittle: FDA scientists say J&J Covid-19 shot is effective; vaccine makers predict big jump in deliveries this month

Three steps can help companies speed FDA approval of new drugs

Access to heart drugs improves in middle-income countries, but still lags compared to wealthy nations

Pharmalittle: Pfizer accused of ‘bullying’ some countries during vaccine talks; FDA to quickly analyze Covid-19 booster shots

Dozens of institutional investors push for ‘fair and equitable’ Covid-19 response

New pledges boost COVAX, but critics say more is needed to ensure global vaccine access

Pharmalittle: Glaxo and Sanofi start new trial of Covid-19 vaccine; AstraZeneca ends a drug’s use for bladder cancer after failed trial

AbbVie smooths over a dispute about alleged theft of trade secrets for a new version of Botox

Up and down the ladder: The latest comings and goings

Pharmalittle: Single Pfizer shot is 85% effective in preventing symptomatic Covid-19; Biden to commit $4 billion to COVAX

Pharmalittle: Pfizer vaccine seems less potent against Covid-19 variant in lab test; WTO urges end to vaccine export restrictions